Process for the synthesis of a conjugate of hyaluronic acid and paclitaxel
AssigneeFidia Farmaceutici S.P.A.
InventorsMonica CAMPISI, Cristian GUARISE, Carlo PIZZOCARO
Life of this patent
Estimating the term…
Abstract
An industrial synthesis process of a hyaluronic acid-paclitaxel conjugate obtained by introducing the 4-bromobutyric acid spacer/linker between the hyaluronic acid and the paclitaxel, said conjugate being characterized by a high purity, the related pharmaceutical compositions for use in the treatment of multiple cancer forms are described.
Claims22
A process for the prepaation and purification of a hyaluronic acid-paclitaxel (HA-paclitaxel) conjugate which comprises or consists of the following steps:
- a) activating in a solution of paclitaxel in an organic solvent, containing a 4-bromobutyric acid spacer/linker, of the carboxyl group of the 4-bromobutyric acid spacer/linker with an activating agent in the presence of a catalyst, thereby obtaining an intermediate of the HA-paclitaxel conjugate;
- b) crystallizing of the intermediate obtained from the previous step a), in an organic solvent, subsequently filtering and drying;
- c) adding the crystallized intermediate obtained in the previous step b) to a TBA (tetrabutylammonium) salt of HA in DMSO;
- d) purifying the HA-paclitaxel conjugate thus obtained which has an ester bond between the carboxyl of the HA polysaccharide and the spacer/linker, said spacer/linker being in turn bound by an ester bond through its carboxyl to the hydroxyl group at carbon C2′ of paclitaxel, by precipitation with an ethanol/water solution containing the NaBr salt, subsequently washing at least once in ethanol/water and further washing in ethanol, pre-drying at 40° C. and passage in a saturated chamber of water vapour at 40° C. and at atmospheric pressure, finally drying at 40° C. under vacuum.
A HA-paclitaxel conjugate having a derivatization or esterification degree within the range of 15% to 21% w/w, preferably within the range of 16% to 20% w/w, wherein the starting hyaluronic acid is of a fermentative origin with an average weight molecular weight ranging from 140,000 to 250,000 Da, said conjugate being in the form of a fine and homogeneous powder, with a degree of purity greater than 98% by weight on the dry product and containing a quantity of di-Br-paclitaxel of less than 1% by weight.
Dependencies are inferred from the claim text.